EUVIMEDEUVIMED entdecken
Crossref

Breakthrough Coronavirus Associated Infectious Disease 2019 After Vaccination Among Kidney Transplant Recipients

Roy O Mathew, Jiajia Zhang, Ziang Liu, Shujie Chen, Cinduja Nathan, Alyssa M Sanchez, Bankole Olatosi, Xiaoming Li, Xueying Yang

Transplantation Proceedings · 2026-04 · 58 (3) · 415-423

DOI: 10.1016/j.transproceed.2026.01.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2026-04. Verfasst von Roy O Mathew und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, Department of Medicine, Loma Linda VA Healthcare System, Loma Linda, California; Department of Medicine, Loma Linda University …. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, COVID-19 Vaccines. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Kidney transplant recipients remain susceptible to severe infectious disease such as the coronavirus associated infectious disease 2019 (COVID-19). Vaccination remains an important step in prevention, but data is needed to support the efficacy in this high-risk population. We sought to evaluate risk factors for breakthrough COVID-19 infection following vaccination among a single US state's resident with kidney transplant (KT). METHODS: Patients with a KT diagnosis prior to the COVID-19 pandemic period from 2019 to 2022 were compared to individuals without KT from a US statewide health registry for South Carolina. Propensity score matching used to match KT and non-KT recipients. Risk of breakthrough infections compared using Cox proportional hazards models. Outcomes (hospitalization and death) associated with breakthrough infection were similarly evaluated. RESULTS: After propensity score matching, 1270 KT and 2540 non-KT remained for analysis. Baseline covariates were well matched. Hazard ratio (HR) and 95% confidence interval (95%CI) for breakthrough COVID-19 infection for KT was 2.61 (1.94, 3.53; p < .001) versus non-KT. Booster vaccination was associated with lower risk for breakthrough vaccination (OR: 0.19, 95% CI: 0.11, 0.27, p < .001). KT patients with breakthrough COVID-19 infection had an odds ratio (OR) of 18 (95% CI 6.5, 61.1; p < .001) for hospitalization and OR 10.2 (95% CI: 2.65, 53.4; p = .002) for death versus non-KT. CONCLUSION: Kidney transplant recipients remain at high risk for breakthrough COVID-19 infection as compared to non-kidney transplant recipients. Vaccination with mRNA-based vaccines and receipt of booster doses appear protective against infection and adverse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19COVID-19 VaccinesHumansFemaleMaleMiddle AgedRisk FactorsBreakthrough InfectionsAdultSARS-CoV-2South CarolinaVaccinationTransplant RecipientsHospitalization

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Division of Medicine, Department of Medicine, Loma Linda VA Healthcare System, Loma Linda, California; Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California. Electronic address: Roy.ma…
  • Department of Epidemiology and Biostatistics, Arnold School of Public Health University of South Carolina, Columbia, South Carolina.
  • Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California.
  • Department of Health Services Policy and Management, Arnold School of Public Health University of South Carolina, Columbia, South Carolina.
  • Department of Health Promotion, Education and Behavior, Arnold School of Public Health University of South Carolina, Columbia, South Carolina.

Förderung

  • National Institute of Allergy and Infectious Diseases Division of Intramural Research

Zitieren

APA

Mathew, R. O., Zhang, J., Liu, Z., Chen, S., Nathan, C., Sanchez, A. M., Olatosi, B., Li, X., & Yang, X. (2026). Breakthrough Coronavirus Associated Infectious Disease 2019 After Vaccination Among Kidney Transplant Recipients. Transplantation Proceedings, 58(3), 415-423. https://doi.org/10.1016/j.transproceed.2026.01.027

Vancouver

Mathew RO, Zhang J, Liu Z, Chen S, Nathan C, Sanchez AM, et al. Breakthrough Coronavirus Associated Infectious Disease 2019 After Vaccination Among Kidney Transplant Recipients. Transplantation Proceedings. 2026;58(3):415-423. doi:10.1016/j.transproceed.2026.01.027

BibTeX
@article{Mathew2026,
  author = {Mathew, Roy O and Zhang, Jiajia and Liu, Ziang and Chen, Shujie and Nathan, Cinduja and Sanchez, Alyssa M and Olatosi, Bankole and Li, Xiaoming and Yang, Xueying},
  title = {Breakthrough Coronavirus Associated Infectious Disease 2019 After Vaccination Among Kidney Transplant Recipients},
  journal = {Transplantation Proceedings},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {415--423},
  doi = {10.1016/j.transproceed.2026.01.027}
}
Kostenlos starten →